可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]余志斌,袁 超.模纹肌浆网Ca2+释放通道的调节[J].心脏杂志,2009,21(4):567-571.
[2]Gyorke S, Terentyev D.Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease[J].Cardiovasc Res,2008,77(2):245-255.
[3]Yamaguchi N,Takahashi N,Xu L,et al.Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel[J].J Clin Invest,2007,117(5):1344-1353.
[4]Zhang T,Kohlhaas M,Backs J,et al.CaMK II delta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses[J].J Biol Chem,2007,282(48):35078-35087.
[5]Sigalas C,Bent S, Kitmitto A, et al. Ca2+-calmodulin can activate and inactivate cardiac ryanodine receptors[J].Br J Pharmacol,2009,156(5):794-806.
[6]Hamada T,Gangopadhyay JP,Mandl A,et al.Defective regulation of the ryanodine receptor induces hypertrophy in cardiomyocytes[J].Biochem Biophys Res Commun,2009,380(3):493-497.
[7]Yeung HM,Kravtsov GM,Ng KM,et al.Chronic intermittent hypoxia alters Ca2+ handling in rat cardiomyocytes by augmented Na+/Ca2+ exchange and ryanodine receptor activities in ischemia-reperfusion[J].Am J Physiol Cell Physiol,2007,292(6):C2046-2056.
[8]An J,Bosnjak ZJ,Jiang MT.Myocardial protection by isoflurane preconditioning preserves Ca2+ cycling proteins independent of sarcolemmal and mitochondrial KATP channels[J].Anesth Analg,2007,105(5):1207-1213.
[9]Lucats L,Vinet L,Bize A,et al.The inotropic adaptation during late preconditioning against myocardial stunning is associated with an increase in FKBP12.6[J].Cardiovasc Res,2007,73(3):560-567.
[10]Sallinen P,Manttari S,Leskinen H,et al. Time course of changes in the expression of DHPR, RyR(2), and SERCA2 after myocardial infarction in the rat left ventricle[J].Mol Cell Biochem,2007,303(1-2):97-103.
[11]Sallinen P,Manttari S, Leskinen H,et al. Long-term postinfarction melatonin administration alters the expression of DHPR, RyR2,SERCA2,and MT2 and elevates the ANP level in the rat left ventricle[J].J Pineal Res,2008, 45(1):61-69.
[12]Lerman BB, Stein KM,Markowitz SM,et al.Ventricular tachycardia in patients with structurally normal hearts[M].//Zipes D,Jalife J.Cardiac electrophysiology:from cell to bedside. 4th edn.Philadelphia:Saunders.2009,668-682.
[13]Cerrone M,Noujaim SF,Tolkacheva EG,et al.Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia[J].Circ Res,2007,101(10):1039-1048.
[14]Watanabe H,Chopra N,Laver D,et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans[J].Nat Med,2009,15(4):380-383.
[15]Tateishi H,Yano M,Mochizuki M,et al.Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2+ leak in failing hearts[J].Cardiovasc Res,2009,81(3):536-545.
[16]Tateishi H,Yano M,Mochizuki M,et al.Defective inter-domain interaction between N-terminal and central domains induces diastolic Ca(2+) leak, leading to heart failure and lethal arrhythmia[J].Cardiovasc Res,2009,81(3):536-545.
[17]Yamamoto T,Yano M, Xu X,et al.Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts[J].Circulation,2008,117(6):762-772.
[18]Kobayashi S,Yano M,Suetomi T,et al.Dantrolene,a therapeutic agent for malignant hyperthermia,markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor[J].J Am Coll Cardiol,2009,53(21):1993-2005.